Deutsche Bank Is Downgrading Quest Diagnostics, But Notes 4 Key Upside Catalysts

By: via Benzinga
Deutsche Bank just issued a report on Quest Diagnostics Inc (NYSE: DGX) downgrading the health care company from Buy to Hold. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.